Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 2Sarcoma 1

Conditions

Sarcoma 10Sarcoma, Ewing 4Liposarcoma 4Rhabdomyosarcoma 3Rhabdoid Tumor 3Osteosarcoma 3Neuroblastoma 3Medulloblastoma 3Glioma 3Wilms Tumor 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Neuroectodermal Tumors, Primitive, Peripheral 2Lymphoma, Non-Hodgkin 2Histiocytosis, Langerhans-Cell 2Hepatoblastoma 2Ependymoma 2Chordoma 2Breast Neoplasms 2Xanthogranuloma, Juvenile 1Urinary Bladder Neoplasms 1Recurrence 1Prostatic Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Liposarcoma, Myxoid 1Histiocytic Sarcoma 1Head and Neck Neoplasms 1Gliosarcoma 1Glioblastoma 1

Interventions

trametinib 1sotorasib 1pembrolizumab 1palbociclib 1atezolizumab 1Pemetrexed 1Panitumumab 1Paclitaxel 1Everolimus 1Drug Therapy 1Docetaxel 1Carboplatin 1Bevacizumab 1Afatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Advanced Solid Tumors × palbociclib × Sarcoma × Clear all
NCT04185883 2025-10-22

Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101)

Amgen

Phase 1 Active not recruiting
610 enrolled
Other solid neoplasmSarcoma

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡